Action Potential Venture Capital Ltd.
Venture capitalScotts Valley · Seed–Late Stage · 3 people tracked
Find your way into Action Potential Venture Capital Ltd.
3,607 people in our graph share verified history with the Action Potential Venture Capital Ltd. team — schools, employers, funds. One of them is your warm intro.
Investment thesis
Action Potential Venture Capital is a corporate venture fund backed by GSK that invests in peripheral neuromodulation medical devices and bioelectronics technologies.
Team · 3 people
from public directories
What they invest in
from 6 of 8 portfolio companiesHealthtech ×6Medical Devices ×6Biotech ×5Deep Tech ×2AI & Machine Learning ×1
HQs:United States×6
Investments · showing 6 of 8
founders shown can be your intro pathBy year:2025 · 42024 · 12018 · 16 dated
Alpheus is a clinical-stage biotechnology company developing Porphyrin Metabolite Activation (PoMA™), a drug-led oncology approach designed to treat glioblastoma using proprietary low-intensity ultrasound to activate tumor-localized porphyrin metabolites.
BiotechHealthtechMedical DevicesChanhassen, US
Jeremy Ling(Executive Officer)inSteve Weiner(Executive Officer)Vijay Agarwal(Founder, President and CEO)inWilliam Davis(Executive Officer, Director)
BoardKlaus Veitinger(Director)inImran Eba(Executive Officer)in
Board seatJuan-Pablo Mas· per SEC Form D · $67M raise · filed Jul 2026
Co-investorsOrbiMedHealthQuest CapitalSamsara BioCapitalSV Health Investors
Exo is a company backed by leading venture capital and corporate investors focused on innovative technologies, with particular emphasis on healthcare, bioelectronic medicines, materials science, and deep technology solutions.
AI & Machine LearningBiotechDeep TechHealthtechMedical Devices
Yusuf Haque(Founder)in
Board seatJuan-Pablo Mas· per SEC Form D · $10M raise · filed May 2025
Co-investorsBold Capital PartnersCreative VenturesPage One VenturesTDK VenturesOSF VenturesSquareOne Capital+1 more
.jpeg){kind=logo}
Neuspera Medical develops an integrated sacral neuromodulation (iSNM) system that implants a smart neurostimulator near the sacral nerve to treat urinary urge incontinence, a symptom of overactive bladder.
BiotechHealthtechMedical DevicesSan Jose, US
Alexander Yeh(Founder)inMilton M. Morris(Executive Officer, Director)inDave Van Meter(Chief Executive Officer)Steve Paul(Chief Commercial Officer)in
Board seatImran Eba· per SEC Form D · $79.6M raise · filed Jun 2021
Co-investorsCerity Partners VenturesForeground CapitalPortfoliaTreo Ventures, LlcWindham Capital PartnersVertex Ventures HC
Saluda Medical develops the Evoke spinal cord stimulation (SCS) system, which records the spinal cord's physiologic response to stimulation using Evoked Compound Action Potentials (ECAPs).
Deep TechHealthtechMedical DevicesBloomington, US
Greg Plamondon(Executive Officer)inKristin Caplice(Executive Officer)inBarry Regan(Executive Officer, Director)inJames Schuermann(Director, Executive Officer)Geoffrey Kinghorn(Director)
Board seatJuan-Pablo Mas· per SEC Form D · $30M raise · filed Nov 2025
Co-investorsFidelity InvestmentsREDMILET. Rowe PriceWellington Management
SetPoint Medical develops an FDA-approved implantable neurostimulation device that stimulates the vagus nerve to reduce inflammation, offering a device-based treatment for adults with moderate-to-severe rheumatoid arthritis who have not responded to biologic or targeted synthetic drugs.
BiotechHealthtechMedical DevicesValencia, US
Murthy Simhambhatla(CEO)inDavid Chernoff(Chief Medical Officer (MD))Yaakov Levine(PhD)inRohan Seth(Executive Officer)in
Board seatJuan-Pablo Mas· per SEC Form D · $115.5M raise · filed Oct 2025
Co-investorsAlly Bridge GroupNew Enterprise Associates (NEA)Norwest Venture PartnersTopspin PartnersCatalio Capital Management, LPCitta Capital+4 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
CALA HEALTH, INC.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Portfolio news
latest coverage across their companies
Saluda Medical · kalkine.com.au · Aug 10, 2026
Alpheus Medical · alpheusmedical.com · Dec 9, 2025
Frequently asked questions
- How many investments has Action Potential Venture Capital Ltd. made?
- Action Potential Venture Capital Ltd. has 8 tracked investments, 1 of which have exited, including 5 dated in the last 24 months.
- What stage does Action Potential Venture Capital Ltd. invest at?
- Action Potential Venture Capital Ltd. invests at the Seed, Series A, Series B, Series C, Late Stage stages.
- What sectors does Action Potential Venture Capital Ltd. focus on?
- Action Potential Venture Capital Ltd. focuses on Medical Devices.
- Where is Action Potential Venture Capital Ltd. located?
- Action Potential Venture Capital Ltd. is headquartered in Scotts Valley, US.
Co-investors · 8
Norwest Venture Partners is an investment firm whose growth equity team backs private, profitable, fast-growing companies, providing capital and hands-on support through its 'invited guest' approach.
OrbiMed is a global healthcare-focused investment firm providing financing and operational support to companies across biopharmaceuticals, medical devices, digital health, diagnostics, and healthcare services.
ShangBay Capital is a venture capital firm that invests in founders building disruptive companies addressing high, unmet clinical needs with novel ideas.
Energy Impact Partners is an investment firm that connects entrepreneurs with major corporate partners to help drive the transformation of the global economy toward a more sustainable future.
Sandbox Industries is an investment firm that fosters innovation in the healthcare and insurance industries, partnering with corporate strategic investors as limited partners alongside financial investors and portfolio companies.
Morgenthaler is a venture capital and private equity firm that has focused on building valuable companies for over 40 years.
Ysios Capital is a life sciences investor that finances innovative biotech companies worldwide, providing resources to develop novel therapies for indications with high unmet medical needs.
Cofounders Capital is a North Carolina-based venture firm that leads seed-stage investments in B2B software companies across the southeastern United States.
Firms observed investing alongside Action Potential Venture Capital Ltd., from public investor directories. Shared companies are the overlap with Action Potential Venture Capital Ltd.'s recorded portfolio.
Similar investors
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
EDBI is the investment platform of Singapore's Economic Development Board and Enterprise Singapore, focusing on high-growth technology companies expanding into Singapore and Asia.
Eight Roads Ventures is a venture capital firm that backs and partners with technology and healthcare companies.
GV (Google Ventures) is a venture capital firm that has invested in artificial intelligence and machine learning since its early days, building a global portfolio of more than 100 AI companies across infrastructure, life sciences, and applications.